A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies
Clinical trial NCT01703572 · COMPLETED
Trial details
- NCT number
- NCT01703572
- Sponsor
- OncoMed Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2016-01-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.